From left, Jimmy Ang, executive chairman, and Chen Heng Hui, CEO
Neoasia pursues regional rollout of medical aesthetics brands backed by science
- The company has more than 50 per cent market share in the plastic surgery, dermatology and medical aesthetics markets of Singapore and Malaysia
Supported by:
Discovery Reports
From left, Jimmy Ang, executive chairman, and Chen Heng Hui, CEO